BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14

• Press Releases

  MiNK Therapeutics Presents Early Observations from Ongoing Phase 2 Trial at the 2026 Military Health System Research Symposium

  August 6, 2026

   · 

  5 min read
• Press Releases

  Northwest Biotherapeutics Announces MOU for Collaboration With the Saudi Pharmaceutical Industries and Medical Appliance Company

  August 6, 2026

   · 

  6 min read
• Press Releases

  Amsino Awarded Vizient Contract for Enteral Syringes

  August 6, 2026

   · 

  1 min read
• Press Releases

  Sumitomo Pharma America Earns 2026-2027 Great Place to Work Certification™

  August 6, 2026

   · 

  3 min read
• 

  Parkinson’s disease

  BioVie shares halve on murky Parkinson’s disease readout

  BioVie’s stock fell by nearly 50% as the biotech claimed victory in a mid-stage Parkinson’s disease trial using an alternative endpoint to the primary clinical goal.

  August 6, 2026

   · 

  3 min read

   · 

  Gabrielle Masson
• Press Releases

  Noveris Health Sciences Inc. Unaware of Any Material Change

  August 6, 2026

   · 

  1 min read
• Press Releases

  Assembly Health Appoints David Millen as Chief Technology Officer

  August 6, 2026

   · 

  3 min read
• 

  Approvals

  Third time’s the charm for Replimune as melanoma drug earns FDA greenlight

  Replimune’s immunotherapy for advanced melanoma faced a perilous regulatory road with two previous rejections, but the drug—to be marketed as Tudriqev—prevailed with strong support from oncologists and a 10-3 advisory committee vote in its favor.

  August 6, 2026

   · 

  3 min read

   · 

  Heather McKenzie
• Press Releases

  Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2026

  August 6, 2026

   · 

  7 min read
• Press Releases

  Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada

  August 6, 2026

   · 

  6 min read